1681 — Consun Pharmaceutical Balance Sheet
0.000.00%
Last trade - 00:00- HK$12.78bn
- HK$8.97bn
- CNY2.97bn
- 100
- 65
- 95
- 99
Annual balance sheet for Consun Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,940 | 2,426 | 3,039 | 3,583 | 3,866 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 458 | 370 | 296 | 310 | 370 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,659 | 3,056 | 3,623 | 4,278 | 4,551 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 676 | 725 | 746 | 739 | 798 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,950 | 4,363 | 4,892 | 5,508 | 5,853 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,332 | 1,357 | 1,350 | 1,495 | 1,371 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,730 | 1,745 | 1,747 | 1,881 | 1,755 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 2,220 | 2,618 | 3,145 | 3,627 | 4,098 |
| Total Liabilities & Shareholders' Equity | 3,950 | 4,363 | 4,892 | 5,508 | 5,853 |
| Total Common Shares Outstanding |